F

Forte Biosciences
D

FBRX

56.590
USD
6.00
(11.86%)
قبل الجلسة·51.880USD-4.710(-8.32%)
حجم التداول
20,419
الربح لكل سهم
-4
العائد الربحي
-
P/E
-12
حجم السوق
1,158,896,254
أصول ذات صلة المقالات
المزيد

العنوان: Forte Biosciences Inc

القطاع: Healthcare
الصناعة: Biotechnology
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.